Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: CERUS CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2021-10-01 to 2023-09-30
Current total value of award: $125840
Description: INTERCEPT PLATELET PATHOGEN REDUCTION (TAMC) - FY23 FUNDS AVAILABILITY